Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8 | 106 | 19 | 174 | 85 |
| TOTAL | $8 | $106 | $19 | $174 | $85 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 4 | 4 |
| TOTAL | $N/A | $N/A | $N/A | $4 | $4 |
| Total Assets | $8 | $106 | $19 | $177 | $89 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 950 | 6,500 | 18 | 11 |
| Accrued Expenses | 103 | 79 | 38 | 38 | N/A |
| TOTAL | $103 | $1,029 | $6,538 | $57 | $2,061 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 953 | 0 | 0 | 6,500 | 6,500 |
| TOTAL | $953 | $N/A | $N/A | $6,500 | $6,500 |
| Total Liabilities | $1,056 | $1,029 | $6,538 | $6,557 | $8,561 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,188 | 1,188 | 1,172 | N/A | 1,164 |
| Common Shares | 214 | 214 | 211 | 211 | 209 |
| Retained earnings | -12,008 | -11,790 | -11,534 | -11,323 | -10,669 |
| TOTAL | $-1,048 | $-923 | $-6,520 | $-6,379 | $-8,473 |
| Total Liabilities And Equity | $8 | $106 | $19 | $177 | $89 |